Nano Silver, also called silver nanoparticles (AgNPs), has a wide range of uses due to its strong antibacterial, antiviral, and antifungal properties, along with its chemical stability and high surface area. Here’s a comprehensive overview: 1. Medical and Healthcare Applications…
Nano Silver, also known as Silver nanoparticles, refers to microscopic particles of silver that range in size from approximately 1 to 100 nanometers (nm). At this nanoscale, silver exhibits unique physical, chemical, and biological properties that differ significantly from bulk…
SLU-PP-332 is an experimental small molecule that activates the estrogen-related receptors ERRα, ERRβ, and ERRγ, with strongest activity toward ERRα. It is often called an “exercise mimetic” because it activates metabolic programs associated with endurance exercise. Importantly, it is not…
SLU-PP-332 is an experimental synthetic small molecule developed through research associated with Saint Louis University and the Burris laboratory. It was designed as an agonist of the three estrogen-related receptors: ERRα (ESRRA) ERRβ (ESRRB) ERRγ (ESRRG) It has attracted attention…
SLU-PP-332 is an experimental small-molecule agonist of the estrogen-related receptors ERRα, ERRβ, and ERRγ. It is often described as an “exercise mimetic” because it activates metabolic programs normally stimulated by aerobic exercise. However, as of 2026, the evidence remains preclinical—primarily…
SLU-PP-332 is a synthetic pan-estrogen-related receptor (ERRα/ERRβ/ERRγ) agonist. ERRs cooperate with metabolic transcriptional programs involving PGC-1α and regulate mitochondrial oxidative metabolism. 1. Improves glucose tolerance in obese mice In diet-induced-obesity mouse models, SLU-PP-332 treatment was associated with improved glucose metabolism,…
SLU-PP-332 is a synthetic estrogen-related receptor (ERR) α/β/γ agonist and experimental “exercise mimetic.” Its strongest activity is toward ERRα, a nuclear receptor that regulates mitochondrial metabolism, oxidative muscle function, and exercise-responsive gene expression. Importantly, the evidence for its efficacy is…
SLU-PP-332 is a synthetic small-molecule pan-estrogen-related receptor (ERRα/ERRβ/ERRγ) agonist developed as an experimental “exercise mimetic.” It is a research compound, not an approved medicine or dietary supplement. Recent analytical work has established LC-HRMS/MS methods for identifying the parent compound and…
SLU-PP-332 is a synthetic small-molecule agonist of the estrogen-related receptors (ERRs)—a family of orphan nuclear receptors involved in regulating mitochondrial activity, oxidative metabolism, fatty-acid utilization, and exercise-responsive gene expression. It is particularly notable because it activates ERRα, ERRβ, and ERRγ,…